Order Code SCERA Saccharomyces cerevisiae Antibody, IgA, Serum
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Useful For
Measuring IgA anti-Saccharomyces cerevisiae antibodies as a part of a profile to aid in distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and imaging evaluations
This test is not useful for determining the extent of disease in patients with inflammatory bowel disease or determining the response to disease-specific therapy including surgical resection of diseased intestine
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name
Saccharomyces cerevisiae Ab, IgA, SSpecimen Type
SerumSpecimen Minimum Volume
0.4 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 21 days | |
Frozen | 21 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | OK |
Heat-treated specimen | Reject |
Reference Values
Negative: <20.0 RU/mL
Positive: ≥20.0 RU/mL
Reference values apply to all ages.
Method Description
Immunoglobulin A (IgA) anti-Saccharomyces cerevisiae antibodies (ASCA) are measured by commercial, microtiter enzyme immunoassay. Partially purified and disrupted S cerevisiae is bound to the wells of a polystyrene microtiter plate coated with purified mannan from the cell wall of S cerevisiae. Prediluted controls and diluted patient sera are added to separate wells, allowing any anti-S cerevisiae antibodies (ASCA) IgG or IgA antibodies present to bind to the immobilized antigen. Unbound sample is washed away, and a horseradish peroxidase-conjugated anti-human IgA antibody is added to each well. A second incubation allows the enzyme-labeled anti-human IgA to bind to any patient antibodies, which have become attached to the microtiter wells. After washing away any unbound enzyme labeled anti-human IgA, the remaining enzyme activity is assessed by adding a chromogenic substrate and measuring the intensity of the color that develops. The assay is evaluated by spectrophotometrically measuring and comparing the color intensity that develops in the patient wells with the color in the control wells. Results of the test for IgA ASCA are reported in relative units per milliliter (RU/mL).(Package insert: Anti-Saccharomyces cerevisiae ELISA (IgA). EUROIMMUN Medizinische Labordiagnostika AG; 05/2011)
Day(s) Performed
Tuesday, Thursday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86671